Back
Roche Holding AG Vs. Novo Nordisk AS Industry Stock Comparison
Sell
29
RHHBY
Roche Holding AG
Last Price:
35.44
Seasonality Move:
-0.52%
Sell
40
NVO
Novo Nordisk AS
Last Price:
105.10
Seasonality Move:
10.2%
Sell
29
Roche Holding AG (RHHBY)
is a Sell
Is Roche Holding AG a Buy, Sell or Hold?
- The current Roche Holding AG [RHHBY] share price is $35.44. The Score for RHHBY is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- RHHBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $105.06. The Score for NVO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RHHBY Stock Price Chart
What is Roche Holding AG's stock price today?
-
The Roche Holding AG share price today is $35.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RHHBY is experiencing selling pressure, which indicates risk of future bearish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $105.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.
RHHBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.07 | Sell |
Relative Strength Index (14 RSI): | 27.68 | Sell |
Chaikin Money Flow: | -357432 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.21 - 39.81) | Sell |
Bollinger Bands (100): | (36.98 - 40.94) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.67 | Sell |
Relative Strength Index (14 RSI): | 41.39 | Sell |
Chaikin Money Flow: | 49323 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.22 - 113.68) | Sell |
Bollinger Bands (100): | (113.16 - 136.4) | Sell |
RHHBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.74 | Sell |
20-day SMA: | 37.52 | Sell |
50-day SMA: | 38.61 | Sell |
200-day SMA: | 35.6 | Sell |
8-day EMA: | 35.87 | Sell |
20-day EMA: | 37.03 | Sell |
50-day EMA: | 38.11 | Sell |
200-day EMA: | 37 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.67 | Buy |
20-day SMA: | 107.35 | Sell |
50-day SMA: | 115.47 | Sell |
200-day SMA: | 127.84 | Sell |
8-day EMA: | 104.35 | Buy |
20-day EMA: | 107.36 | Sell |
50-day EMA: | 114.34 | Sell |
200-day EMA: | 120.49 | Sell |
Roche Holding AG Earnings Growth & RHHBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.29 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.74 per share.
Roche Holding AG Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |